Meghmani Organi. Q1 FY27 Earnings Call — Analysis (NSE: MOL)

Despite 12% YoY revenue decline to ₹542 Cr, Meghmani Organics Q1FY27 consolidated net profit surged 280% YoY to ₹48.2 Cr, driven by margin expansion across segments.

· Analysis by Alpha Inflection

The take

Q1FY27 Revenue (Consolidated) ₹542 Cr ( −12% YoY ) .

Results

Consolidated revenue ₹542 Cr (-12% YoY), net profit ₹48.2 Cr (+280% YoY), EBITDA ₹97.9 Cr (+46% YoY), EBITDA margin 18% (vs 10.9% YoY).

Financial highlights

Meghmani Organi. Q1 FY27 reported figures
MetricValueChangeBasis
Revenue (Standalone)₹523 Cr−12%yoy · Q1FY27
Net Profit (Standalone)₹58 Cr+42%yoy · Q1FY27
EBITDA (Standalone)₹94 Cr+16%yoy · Q1FY27
Revenue (Consolidated)₹542 Cr−12%yoy · Q1FY27
Net Profit (Consolidated)₹48.2 Cr+280%yoy · Q1FY27
EBITDA (Consolidated)₹97.9 Cr+46%yoy · Q1FY27
EBITDA Margin (Consolidated)18%+7.1 pptyoy · Q1FY27
Total Debt (Standalone)₹555 Crpoint_in_time · as of 30 Jun 2026
Total Debt (Consolidated)₹732 Crpoint_in_time · as of 30 Jun 2026
Debt Repayment (Consolidated)₹32 Crnone · Q1FY27

Guidance

Crop Protection guided for double-digit FY27 revenue growth with 15-17% EBITDA margin; Pigment revenue ₹500-600 Cr, ~10% margin; Crop Nutrition targeted 'couple of INR100 crores' revenue over 2-3 years; debt repayment ₹130 Cr in FY27.

What management committed to

Key themes

Margin resilience in weak demand environment

Operational commentary

Analyst Q&A

View source

Research and educational content only. Not investment advice.